Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis.
Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis.
复制标题
调节性T细胞对肝转移瘤全身免疫和免疫治疗反应的控制。
DOI:
10.1126/sciimmunol.aba0759
复制
发表时间:
2020-10-02
影响因子:
24.8
通讯作者:
Bluestone JA
中科院分区:
文献类型:
--
作者:
Lee JC;Mehdizadeh S;Smith J;Young A;Mufazalov IA;Mowery CT;Daud A;Bluestone JA
Cancer patients with liver metastasis demonstrate significantly worse outcomes than those without liver metastasis when treated with anti-PD-1 immunotherapy. The mechanism of liver metastases-induced reduction in systemic antitumor immunity is unclear. Using a dual-tumor immunocompetent mouse model, we found that the immune response to tumor antigen presence within the liver led to the systemic suppression of antitumor immunity. The immune suppression was antigen-specific and associated with the coordinated activation of regulatory T cells (Tregs) and modulation of intratumoral CD11b+ monocytes. The dysfunctional immune state could not be reversed by anti-PD-1 monotherapy unless Treg cells were depleted (anti-CTLA-4) or destabilized (EZH2 inhibitor). Thus, this study provides a mechanistic understanding and rationale for adding Treg and CD11b+ monocyte targeting agents in combination with anti-PD-1 to treat cancer patients with liver metastasis.
登录
查看更多内容
影响因子:
--
作者:
Budczies J;von Winterfeld M;Klauschen F;Bockmayr M;Lennerz JK;Denkert C;Wolf T;Warth A;Dietel M;Anagnostopoulos I;Weichert W;Wittschieber D;Stenzinger A
通讯作者:
Stenzinger A
影响因子:
8.8
作者:
Holmgaard RB;Zamarin D;Li Y;Gasmi B;Munn DH;Allison JP;Merghoub T;Wolchok JD
通讯作者:
Wolchok JD
影响因子:
24.8
作者:
Ahmadzadeh, Mojgan;Pasetto, Anna;Rosenberg, Steven A.
通讯作者:
Rosenberg, Steven A.
DOI:
10.1073/pnas.0408197102
发表时间:
2005-01-11
影响因子:
11.1
作者:
Chen, ML;Pittet, MJ;Khazaie, K
通讯作者:
Khazaie, K
影响因子:
2.4
作者:
Brown, Zachary J.;Heinrich, Bernd;Greten, Tim F.
通讯作者:
Greten, Tim F.